Bill Mannina
Analyst · ROTH Capital. Please go ahead
Thanks, Caesar. Earlier today, we issued our Q3 earnings press release announcing the operating and financial results for our fiscal 2022 third quarter ended September 30. For the third quarter, we recognized approximately $223,000 in revenue, a decrease of 4% compared to approximately $233,000 in the prior quarter and an 11% increase compared to approximately $201,000 in the same quarter of last year. Cost of revenue for Q3 was approximately $420,000, an increase of $149,000 over the prior quarter, which was due to product sales making up a larger percentage of our revenue in Q3 and also an inventory write-down. We did not report any cost of revenue in Q3 of 2021. Total GAAP cost and expenses for the third quarter totaled $6.3 million, approximately $1 million lower than the total costs and expenses of last quarter, which was mainly due to an approximately $600,000 decrease in severance expense and a $300,000 decrease in R&D expense due mainly to decreases in recruiting expense and chip design expense. Compared to the third quarter of last year, total GAAP cost and expenses was approximately $6.3 million lower, which was mainly due to a $4 million decrease in severance expense, a $1.9 million decrease in R&D due primarily to an approximately $900,000 decrease in stock comp expense, and a $450,000 decrease in payroll expense and also a decrease of approximately $800,000 in sales and marketing due primarily to an approximately $450,000 decrease in stock comp expense and a $200,000 decrease in payroll expense. Year-to-date, our total GAAP cost and expenses was $21 million, approximately $11.5 million lower than the $32.5 million of Q3 year-to-date GAAP expense in fiscal 2021, a decrease of just under 36%. The decrease year-over-year was primarily due to an approximately $6.2 million decrease in stock comp expense, a $3.4 million decrease in severance, and a $1.9 million decrease in payroll expense, which are partially offset by a $900,000 increase in cost of revenue. The net loss for the third quarter on a GAAP basis was $6 million or an $0.08 loss per share on 77.6 million weighted average shares outstanding. This compares to a $7 million net loss in Q2 or $0.09 per share and at $12.5 million net loss or $0.20 per share on 63 million weighted average shares outstanding in Q3 of 2021. The year-over-year increase in the share count was mainly due to shares added from our at-the-market offering or ATM facility in the fourth quarter of 2021, which raised an additional net $27 million of cash and added 12.2 million shares. Now for a non-GAAP view of our numbers for the quarter, as we believe non-GAAP information provides a useful comparison for investors, especially for a company at our stage when used with GAAP information. Excluding approximately $698,000 of stock-based comp and approximately $74,000 of depreciation expense, from our total Q3 GAAP cost and expenses of $6.3 million, net non-GAAP cost and expenses totaled approximately $5.6 million, a decrease of approximately $470,000 compared to Q2 and a decrease of approximately $1.1 million compared to Q3 of last year. The decrease compared to Q2 was mainly due to decreases in recruiting and annual shareholder meeting costs partially offset by an increase in cost of revenue. The decrease compared to Q3 of 2021 was mainly due to reduced headcount in research and development and sales and marketing and also decrease in recruiting fees again partially offset by an increase in revenue – cost of revenue, sorry. Our non-GAAP net loss for Q3 was approximately $5.2 million and approximately $560,000 lower loss compared to Q2 and an approximately $1.3 million lower loss compared to Q3 of last year. Non-GAAP research and development expense was $2.6 million and approximately $330,000 decrease versus the prior quarter and approximately $930,000 decrease compared to the same period last year. The decrease compared to Q2 was mainly due to decreases in recruiting and chip development costs. The decrease compared to Q3 of 2021 was mainly due to decreases in payroll expense, chip development costs and consulting costs. Non-GAAP SG&A expense was $2.6 million, a decrease of approximately $300,000 versus the prior quarter and a decrease of approximately $600,000 compared to Q3 last year. The decrease compared to Q2 was mainly due to decreases in recruiting and annual shareholder meeting costs. The decrease compared to Q3 of 2021 was mainly due to decreases in recruiting and consulting costs. Year-to-date, our total non-GAAP cost and expenses was $18.1 million, $1.9 million lower than the $20 million of Q3 year-to-date non-GAAP expense in fiscal 2021. The decrease was mainly due to an approximately $1.9 million decrease in payroll expense, a $500,000 decrease in legal expense, and a $500,000 decrease in chip development costs partially offset by an increase of approximately $900,000 in cost of revenue. Turning to the balance sheet, we ended Q3 with $30.4 million in cash and remain debt free. We expect our GAAP and non-GAAP cash operating expenses for the full year to trend in the current range with our normal quarterly fluctuations. Also, as mentioned earlier, we continue to forecast year-over-year revenue growth. I will now give the call back to the operator for the question-and-answer session.